Smartstep Smartphone PAD
SMARTSTEP
Smartphone-Enabled Supervised Exercise Therapy for the Treatment of Symptomatic Peripheral Arterial Disease
1 other identifier
interventional
46
1 country
1
Brief Summary
The study aim is to evaluate the effectiveness of a coached, smartphone-enabled exercise program versus physician directed exercise therapy (usual care).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Aug 2018
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 21, 2018
CompletedFirst Posted
Study publicly available on registry
March 27, 2018
CompletedStudy Start
First participant enrolled
August 24, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 20, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
February 20, 2025
CompletedMarch 13, 2025
March 1, 2025
6.5 years
March 21, 2018
March 11, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change in 6-minute walk test (6MWT) distance completed
The 6 Minute Walk Test is a sub-maximal exercise test used to assess aerobic capacity and endurance. The distance covered over a time of 6 minutes is used as the outcome by which to compare changes in performance capacity.
Immediately before and after the 12-week period
Secondary Outcomes (9)
Change in Walking Impairment Questionnaire (WIQ) score
Immediately before and after the 12-week period
Change in Physical Health Composite Score of SF-36
Immediately before and after the 12-week period
Change in claudication onset time during 6MWT
Immediately before and after the 12-week period
Change in ankle-brachial pressure index (ABPI)
Immediately before and after the 12-week period
Change in number of steps/week
Immediately before and after the 12-week period
- +4 more secondary outcomes
Study Arms (2)
Smartphone-enabled structured exercise therapy (SE-SET)
EXPERIMENTALThis arm involves a smartphone app Movn - rehabilitation platform based on MULTIFIT, a case-management system for secondary prevention and patient surveillance after acute MI. The key features of the smartphone app include daily reminders to exercise, virtual diary for patients to enter data on exercise sessions, two-way secure messaging with the health coach, and educational videos on heart and vascular health.
Standard exercise therapy
ACTIVE COMPARATORSelf-directed, unsupervised exercise as prescribed by the patient's physician.
Interventions
The SE-SET program lasts a total of 12 weeks per participant. During this time, the application will automatically track physical activity (steps) and subjects will be prompted to enter other health data such as blood pressure and weight and watch brief educational videos on topics such as smoking cessation, low sodium diet, high fruit/vegetable intake, and medication adherence/education. Patients will be contacted by a member of the study team weekly via phone call to identify barriers to patient compliance (issues related to exercise tracking, medication issues that prevent patients from being active, high BP/weight issues) and help patients navigate those barriers. Movn participants can also send direct messages to the study team to ask about non-urgent matters related to their care.
The Standard exercise therapy lasts a total of 12 weeks per participant. Participants will be counseled by the physician to perform exercise at home, including 3 times per week of walking 30+ minutes; if applicable, the physician will also counsel on smoking cessation, low sodium diet, high fruit/vegetable intake, and medication adherence/education. These patients will be given a fitness band, which will be set up by the study team using a de-identified study account that will provide additional data on their progress over time.
Eligibility Criteria
You may qualify if:
- Clinically stable intermittent claudication
- Able to give informed consent
- Age 18-89 years
- And one of the following:
- ABI \< 0.9 after 10 minutes of rest OR
- For subjects with an ABI of \>1.3 (non-compressible arteries) a Toe-Brachial Index (TBI) of \< 0.70 must be obtained for subject qualification. If ABI is \> 0.9 to 1.0, a reduction of 20% in ABI must be measured within 1 minute of treadmill testing.
You may not qualify if:
- Life-threatening process including:
- Sepsis
- Critical limb ischemia (Rutherford class 4-6)
- Unstable angina
- Active malignancy with life expectancy \< 6 months
- Severe NYHA Class IV heart failure
- Condition other than PAD that limits walking before claudication onset
- This includes, but is not limited to:
- Severe angina or dyspnea
- Arthritis
- Muscle weakness/pain
- Active behavioral conditions such as uncontrolled schizophrenia or illicit drug addiction that, in the opinion of the study team, will interfere with active participation
- Inability to attend study visits
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Emory Universitylead
- Woodruff Health Sciences Center Foundationcollaborator
Study Sites (1)
Grady Health System (non-CRN)
Atlanta, Georgia, 30303, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Amit Shah, MD
Emory University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor
Study Record Dates
First Submitted
March 21, 2018
First Posted
March 27, 2018
Study Start
August 24, 2018
Primary Completion
February 20, 2025
Study Completion
February 20, 2025
Last Updated
March 13, 2025
Record last verified: 2025-03